Literature DB >> 9103671

Taenia solium cysticercosis: host-parasite interactions and the immune response.

A C White1, P Robinson, R Kuhn.   

Abstract

Taenia parasites have developed elaborate mechanisms of interacting with their intermediate hosts. The oncospheres which invade the intermediate host are susceptible to antibody and complement. However, by the time the host has generated an antibody response, the parasites have begun to transform to the more resistant metacestode. The metacestodes have elaborate means of evading complement-mediated destruction, including paramyosin which inhibits C1q, taeniaestatin which inhibits both classical and alternate pathways, and sulfated polysaccharides which activate complement away from the parasite. Similarly, antibody does not seem to be able to kill the mature metacestode. In fact, the parasites may even stimulate the host to produce antibody, which could be bound via Fc receptors and used as a source of protein. Finally, taeniaestatin and other poorly defined factors may interfere with lymphocyte proliferation and macrophage function, thus paralyzing the cellular immune response. Since the symptoms of NCC are typically associated with a brisk inflammatory response, we hypothesize that disease is primarily caused by injured or dying parasites. This hypothesis raises important questions in assessing the role of chemotherapy in the management of NCC, as well as in the evaluation of clinical trials, most of which were uncontrolled.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103671

Source DB:  PubMed          Journal:  Chem Immunol        ISSN: 0079-6034


  41 in total

1.  Parasites in fine needle breast aspirates--assessment of host tissue response.

Authors:  K Sahai; K Kapila; K Verma
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

2.  Back to the ring: knocking-out headache.

Authors:  Marco Tironi; Lucio Tremolizzo; Giovanni Stefanoni; Monica Airoldi; Eleonora Motta; Mirko Patassini; Francesco Canonico; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2011-11-29       Impact factor: 3.307

Review 3.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 4.  Neurocysticercosis--New Millennium, ancient disease and unending debate.

Authors:  G Narula; K S Bawa
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

5.  Taenia solium cysticerci synthesize androgens and estrogens in vitro.

Authors:  R A Valdéz; P Jiménez; A L Cartas; Y Gómez; M C Romano
Journal:  Parasitol Res       Date:  2006-01-14       Impact factor: 2.289

6.  Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.

Authors:  Jorge I Alvarez; Judy M Teale
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

7.  Neurocysticercosis: local and systemic immune-inflammatory features related to severity.

Authors:  Brenda Sáenz; Agnes Fleury; Anahí Chavarría; Marisela Hernández; José C Crispin; María I Vargas-Rojas; Gladis Fragoso; Edda Sciutto
Journal:  Med Microbiol Immunol       Date:  2011-06-23       Impact factor: 3.402

Review 8.  Laboratory Diagnosis of Neurocysticercosis (Taenia solium).

Authors:  Hector H Garcia; Seth E O'Neal; John Noh; Sukwan Handali
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

Review 9.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Kondi Wong; Judy M Teale
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.